This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN advanced 5.82% to $2.91 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.45% to 3,801.78 and Dow Jones Industrial Average DJIA falling 0.67% to 30,772.79. The stock's rise snapped a two-day losing streak. Ocugen Inc. closed $14.74 short of its 52-week high ($17.65), which the company reached on November 3rd.
The stock outperformed some of its competitors Wednesday, as Adverum Biotechnologies Inc. ADVM rose 0.57% to $1.75, Ocular Therapeutix Inc. OCUL rose 4.18% to $4.49, and Kodiak Sciences Inc. KOD fell 1.51% to $9.14. Trading volume (6.6 M) remained 380,133 below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2022.
(END) Dow Jones Newswires
July 13, 2022 17:14 ET (21:14 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.